Haleon

Haleon To Sell ChapStick To Yellow Wood For About €468m

Britain's Haleon said it had agreed to sell lip balm brand ChapStick to a company owned by private equity firm Yellow Wood Partners.

Sir Dave Lewis Named Operating Advisor To CD&R Funds

US investment firm Clayton, Dubilier & Rice (CD&R) has appointed Sir Dave Lewis as an operating advisor to CD&R funds.

Haleon Misses Revenue Estimates As North America Demand Drags

Haleon missed market estimates for third-quarter revenue, as the world's largest consumer healthcare firm grappled with weak demand for its painkillers, di...

France's Sanofi Considers Listing Consumer Unit Late Next Year

Sanofi has mapped out a separate listing of its consumer healthcare business from the fourth quarter of next year, the French drugmaker said, adding it pla...

Kenvue Cuts Annual Profit Forecast On Soft Demand For Cold, Flu Medicines

Kenvue cut the higher end of its annual profit forecast, as the Benadryl maker saw weakness in demand for its cold and flu medicines and an increased impac...

The Consumer Goods Forum Sustainable Retail Summit Review: Friday

The importance of "being bold" and "convincing others" was the opening topic of conversation on the final day of The Consumer Goods For...

GSK Cuts Stake In Haleon To 7.4%, Raises £885.6m

British drugmaker GSK said it raised £885.6 million (€1 billion) from a discounted stake sale in Haleon, cutting its shareholding to 7.4%.

Haleon Raises Annual Organic Revenue Growth Forecast On Steady Demand

Haleon has raised its forecast for annual organic revenue growth, as the consumer healthcare company is confident that demand for its oral and respiratory...